TT-9701

N/A

Report date: 2025/04/11 17:58:12
NME

Base Information

Drug NameTT-9701
Drug Alias NameTT-9701TT9701
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of SciencesZhejiang UniversityZhongshan Institute for Drug Discovery +[4] 
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesYantai New Drug Creation Shandong LaboratoryZhongshan Institute for Drug DiscoveryZhejiang University +[4] 
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A